Meis1は,産後心筋細胞の細胞サイクル停止を調節する
Ahmed I Mahmoud1, Fatih Kocabas1, Shalini A Muralidhar1
1Department of Internal Medicine, Division of Cardiology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390, USA.
Nature
|April 19, 2013
まとめ
新生児の心臓は,心筋細胞の増殖によって再生しますが,この能力は出生後に失われます. Meis1 (転写因子) は,この細胞サイクルを制御し,心臓再生療法のためのターゲットを提供します.
科学分野:
- 心血管生物学 心血管生物学
- 発達生物学 発達生物学について
- 分子心臓病学 分子心臓病学
背景:
- 新生児の哺乳類の心臓は,心筋細胞の増殖を通じて,重要な再生能力を発揮します.
- この再生能力は産後7日目までに低下し,心筋細胞の細胞サイクル停止のメカニズムは完全に理解されていません.
- ホメオドメインの転写因子Meis1は心臓の発達に不可欠ですが,心臓肌細胞におけるその特定の役割は不明です.
研究 の 目的:
- Meis1が心筋細胞の増殖と細胞サイクルを調節する役割を調査する.
- Meis1が心筋細胞再生能力の窓に影響するかどうかを判断する.
- Meis1を心臓の再生を促進する潜在的な治療標的として調査する.
主な方法:
- Meis1を消去または過剰に発現させるため,マウスモデルで遺伝子操作を行いました.
- 異なる産後段階および成人心臓における心筋細胞増殖と細胞サイクル状態の評価.
- Meis1の転写標的を分析し,細胞サイクル阻害剤に焦点を当てました.
主要な成果:
- Meis1の消去により,心筋細胞の産後増殖期が延長され,心筋細胞のミトーシスが再活性化され,心臓の機能は損なわれませんでした.
- Meis1過剰発現は新生児の心筋細胞増殖を減少させ,新生児の心臓再生を阻害した.
- Meis1は,CDK阻害剤p15,p16,p21.の転写活性化に不可欠であることが判明しました.
結論:
- Meis1は,心筋細胞増殖の重要な転写調節体として作用する.
- Meis1は,心筋細胞の細胞サイクル終了を制御し,それによって心臓の再生を制限します.
- Meis1をターゲットにすることは,心臓の修復と再生を強化するための潜在的な治療戦略を提示します.
関連する概念動画
01:28The Cell Cycle Control System
The cell cycle regulation directs how a cell proceeds from one phase to the next and begins mitosis. The cell cycle control system includes intracellular regulatory molecules and external triggers. They provide "stop" or "advance" signals and operate at specific cell cycle stages termed checkpoints to ensure that a particular process is completed before the cell advances to the next phase.
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
Cyclins and cyclin-dependent kinases (Cdks) are the primary cell cycle regulators and function at the cell...
02:38Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
02:34Inhibition of Cdk Activity
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
02:36Cells Coordinate Growth and Proliferation
Cell size is a significant factor impacting cellular design, function, and fitness. There exists some internal coordination by which cells double their masses before division, thus, achieving homeostasis. Coordination between cell growth and proliferation depends on the checkpoints in between cell cycle phases. Loss of coordination or failure in the checkpoint mechanism can drive the cell to uncontrolled growth and loss of cellular function. Like dividing cells that coordinate cellular growth,...
02:39Positive Regulator Molecules
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
02:15M-Cdk Drives Transition Into Mitosis
Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...